During the past decade, Unidad de investigación en enfermedades crónico - degenerativas SC conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 12 clinical trials were completed, i.e. on average, 240% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 8 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Unidad de investigación en enfermedades crónico - degenerativas SC" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Pfizer" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "EMD Serono" with 1 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Unidad de investigación en enfermedades crónico - degenerativas SC" #1 collaborator was "Immune Tolerance Network (ITN)" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Unidad de investigación en enfermedades crónico - degenerativas SC" are "Rheumatoid Arthritis" (3 trials), "Arthritis, Rheumatoid" (2 trials), "Lupus Erythematosus, Systemic" (2 trials), "Lupus Nephritis" (2 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Unidad de investigación en enfermedades crónico - degenerativas SC" in a lesser frequency.

Most popular intervention types in "Unidad de investigación en enfermedades crónico - degenerativas SC" are "Drug" (13 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "CP-690,550" (2 trials), "Methotrexate" (2 trials), "Tocilizumab" (2 trials) and "Atacicept 150 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Unidad de investigación en enfermedades crónico - degenerativas SC" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Unidad de investigación en enfermedades crónico - degenerativas SC". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Unidad de investigación en enfermedades crónico - degenerativas SC, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Unidad de investigación en enfermedades crónico - degenerativas SC, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".